Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Daunowel Daunorubicin Injection 20 mg
Daunowel is a potent chemotherapy agent designed to combat acute leukemias by effectively targeting and destroying rapidly dividing cancer cells. It is a key component in combination chemotherapy regimens for leukemia patients.
Uses of Daunowel Daunorubicin Injection 20 mg
Treatment of acute myeloid leukemia (AML)
Management of acute lymphoblastic leukemia (ALL)
Used in combination chemotherapy protocols
Benefits of Daunowel Daunorubicin Injection 20 mg
Highly effective against rapidly growing leukemia cells
A critical component in standard leukemia treatment regimens
Targets DNA replication to induce cancer cell death
Administered under expert oncological supervision for maximum efficacy
Mechanism of Action of Daunowel Daunorubicin Injection 20 mg
Intercalates between DNA base pairs, disrupting replication and transcription.
Inhibits topoisomerase II, preventing DNA repair and leading to cell death.
Generates free radicals, contributing to apoptosis of malignant cells.